An observational study profiling biospecimens from 10,000 metastatic prostate cancer (mPCa) patients to screen for molecular alterations. Background: Resistance to AR-targeted therapy is a challenge ...
Impact of relacorilant, a selective glucocorticoid receptor antagonist, on the immunosuppressive effects of endogenous cortisol.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results